Hualan Biological Bacterin Inc.’s Net Profit Dropped 4.4% in First Three Quarters of 2022

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 504.7 million yuan in the first three quarters of 2022, down 4.4% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 12% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 23.7%.